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Aims: The objective of this study was to investigate the effect of preoperative mild renal
dysfunction (RD), not requiring dialysis, on mortality and morbidity after valve cardiac
surgery (VCS).
Population: We studied 340 consecutive patients (2008–2012), who underwent VCS with or
without coronary artery bypass graft (CABG).
Methods: Preoperative RD was calculated with the abbreviated Modiﬁcation of Diet in Renal
Disease formula and was deﬁned as a glomerular ﬁltration rate <60 ml/min/1.73 m2. Logistic
regression analysis was used to assess the effect of preoperative renal dysfunction (RD) on
operative and adverse outcomes.
Results: 80 patients (30%) had preoperative mild RD. Patients with preoperative RD were
older, had a higher rate of preoperative anemia (43% vs. 25%, p < 0.001), and more comor-
bidities. Patients with preoperative RD had worse outcomes with more reoperation (6.8% vs.
2.3%, p < 0.001).
Conclusion: Preoperative RD was signiﬁcantly and independently associated with more red
blood cell transfusions and longer hospital stay (median 9 vs. 8 days, p < 0.001). Mortality
was similar in both groups (3.4% vs. 2.3%, p = 0.43). Preoperative mild RD in patients
undergoing cardiac valve surgery is an independent marker of postoperative morbidity.
# 2015 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.
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Preoperative renal dysfunction (RD) not requiring dialysis is a
recognized risk factor for postoperative morbidity and
mortality after coronary artery bypass graft (CABG).1–5
Outcome research in valve cardiac surgery (VCS) has been* Corresponding author.
E-mail address: hadyaboaljadayel@yahoo.com (H.A. Aljadayel).
http://dx.doi.org/10.1016/j.ihj.2015.07.044
0019-4832/# 2015 Cardiological Society of India. Published by Elseviewidely studied, but the impact of preoperative RD on valve
replacement outcome is not well known. In one study,8 mild
RD was independently associated with adverse outcome and
most of the patients were men. The association between
preoperative mild RD and adverse effects after cardiac
surgery was stronger when renal function was analyzed by
estimated glomerular ﬁltration rate (GFR)9 using serumr B.V. All rights reserved.
i n d i a n h e a r t j o u r n a l 6 8 ( 2 0 1 6 ) 1 3 8 – 1 4 2 139creatinine-based prediction equations than by serum creati-
nine level.
Preoperative anemia has been associated with a higher in-
hospital mortality and morbidity after elective valve replace-
ment.10 An interaction exists between chronic kidney disease
(CKD) and anemia that worsens outcome in congestive heart
failure,11 conditions that are also frequently present in cardiac
surgery patients and might increase risk after surgery.
The aim of our study was to investigate whether preopera-
tive RD is a risk marker for mortality and morbidity in patients
who underwent VCS. A secondary objective was to examine
the relationship between preoperative RD and anemia with
outcomes in VCS.
2. Methods
2.1. Data
We studied 340 consecutive patients undergoing cardiac valve
surgery (both repair and replacement) with or without
combined CABG between January 2008 and July 2012. Patients
on chronic dialysis were excluded. The study was based on
data collected from routine care, and thus individual consent
was waived. Our database was initiated in January 2008
coinciding with the implementation of cardiac surgery in
Aleppo university hospital for cardiac surgery. The database
was designed to prospectively collect data of all patients
undergoing cardiac surgery. It contains detailed information of
demographic data, risk factors, clinical preoperative charac-
teristics, operative description, including location and catego-
ry of operated valve, postoperative complications, operative
mortality, and postoperative length of hospitalization.
2.2. Surgical and postoperative aspects
All the patients underwent cardiac surgery through medium
sternotomy and standard cardiopulmonary bypass. They were
operated on under passive moderate hypothermia and myocar-
dial protection was accomplished with antegrade or antegrade–
retrograde crystalloid cold cardioplegia. Antibiotic prophylaxis
with ﬁrst-generation cephalosporins (Cefazolin, iv) was begun
just before the onset of surgical intervention and was discon-
tinued after 24 h in the ICU. Patients were transferred to the ICU,
and they were mechanically ventilated and sedated. During the
postoperative period, patients were treated at the ICU following
the same standard care. Extubation was done in awake and
stable patients according to well-established criteria. Criteria for
transfusion of red blood cells (RBCs) depended ultimately on
the physician in charge of the patient, but we transfused when
the hemoglobin was lower than 8 g/dl, lower than 10 g/dl in
patients with myocardial or cerebral dysfunction, and during
severe active bleeding. From the second postoperative day,
patients were transferred to the cardiac surgery ward, consider-
ing that they did not need intensive care treatment.
2.3. Data deﬁnition
Preoperative risk factors such as age, gender, weight, body
mass index, habit of smoking, hypertension, diabetes, andanemia (Hb level < 12 g/dl) were included. Associated comor-
bidities, such as chronic obstructive pulmonary disease
(COPD), peripheral vascular disease, stroke, left ventricular
dysfunction (ejection fraction <30%), atrial ﬁbrillation, previ-
ous cardiac surgery, angina, and myocardial infarction, were
included. Global preoperative risk was calculated by logistic
and additive EuroSCORE.
2.4. Renal function
Preoperative serum creatinine (Cr) was determined in all
patients within two days of cardiac surgery. Estimated GFR
was calculated following the abbreviated Modiﬁcation of Diet
in Renal Disease (MDRD) formula12
GFR ¼ 186:3ðSerum creatinineÞ1:154ðageÞ0:203
1:212 ðif blackÞ0:742 ðif femaleÞ
Serum creatinine is measured in mg/dl, age in years, and
GFR is expressed in ml/min per 1.73 m2. Preoperative RD was
deﬁned as an estimated GFR value <60 ml/min/1.73 m2.
Postoperative RD was deﬁned13 as a postoperative increase
in serum creatinine level >25% from preoperative baseline
value or an increase >0.5 mg/dl. Percent change in serum
creatinine (% DCr) was calculated by: [(highest postoperative
Cr)/(preoperative Cr)  1]  100. We recorded the requirements
for renal replacement therapy (RRT) during hospitalization.
2.5. Outcome
The primary outcomes of this study were mortality and
hospital morbidity. Mortality was deﬁned as death occurring
during hospital stay or within 30 days after hospital discharge.
Hospital morbidity was deﬁned as mechanical ventilator
support for 24 h, and postoperative renal, cardiac, neurologi-
cal, pulmonary, gastrointestinal, and vascular complications.
Major adverse cardiac events were deﬁned as cardiac arrest or
cardiogenic shock. Postoperative atrial arrhythmia was de-
ﬁned as the occurrence of a new atrial arrhythmia in the
absence of preoperative arrhythmias. Perioperative acute
myocardial infarction was deﬁned as the presence of typical
acute ischemic ECG changes and or a CK-MB value greater than
ﬁve times the upper limit of normal. We deﬁned postoperative
stroke by the presence of a new focal neurological deﬁcit
persisting for at least 24 h conﬁrmed by CT-scan. Postoperative
bleeding was deﬁned as any bleeding that required surgical
reoperation after initial departure from the operating theatre.
Criteria for diagnosing mediastinitis and pneumonia were in
accordance with the guidelines published by the Centers for
Disease Control and Prevention.
The length of mechanical ventilation was the time that the
patient needed ventilator support after cardiac surgery from
ICU admission to extubation. Postoperative hospital length of
stay was the time that the patient remained in hospital since
cardiac surgery to discharge and ICU length of stay was the
time the patient spent in the ICU after cardiac surgery.
2.6. Statistical analysis
Continuous variables are presented as mean with standard
deviation (S.D.) or median with interquartile range when
i n d i a n h e a r t j o u r n a l 6 8 ( 2 0 1 6 ) 1 3 8 – 1 4 2140appropriate. Categorical variables were expressed as real
numbers and percentages. Categorical variables were ana-
lyzed using Pearson x2-tests or Fisher's exact tests. Continuous
variables were evaluated using the Student's t-test or the
Mann–Whitney U-test, if not normally distributed. Logistic
regression analysis was used to examine the relationship
between preoperative renal function and postoperative out-
comes. Stepwise selection of variables with p ≤ 0.05 in the
Univariate analysis was performed and variables were
retained when p ≤ 0.05. Statistical analyses were done with
SPSS 18.0 (SPSS, Inc., Chicago, IL). A p-value <0.05 was
considered statistically signiﬁcant.
3. Results
3.1. Preoperative data
A total of 80 patients (30%) had preoperative RD not requiring
dialysis. Table 1 shows the distribution of comorbid risk factors
across patients with and without preoperative RD. A total of 80
patients (30%) had preoperative anemia and the incidence was
signiﬁcantly higher in patients with preoperative RD (43% vs.
25%, p < 0.001). Creatinine levels were signiﬁcantly higher in
this group (1.5  0.5 vs. 0.89  0.2 mg/dl, p < 0.001). The use of
angiotensin-converting enzyme (ACE) inhibitors was higher
in patients with RD (52%) than in patients without RD (39%,
p < 0.001), and beta blockers (26%) and aspirin (27%) were used in
a similar manner in both groups.
3.2. Preoperative data
Within this population (Table 2), 241 patients (71%) underwent
VCS and 99 patients (29%) had combined CABG and valvular
surgery. A total of 10 (2.8%) patients were operated for activeTable 1 – Characteristics of study patients categorized by preo
Total patients
(n = 340)
Age in years* 68 (59–75) 
Female gender 153 (45%) 
Height in cm 161  9.3 
Weight in kg 73  13.3 
BMI 28  4.9 
Hypertension* 194 (57%) 
Current smoker 45 (13%) 
Insulin dependent diabetes 20 (6%) 
Non-insulin dependent diabetes 71 (21%) 
Peripheral vascular disease** 14 (4.4%) 
Stroke 34 (10%) 
COPD 40 (12%) 
Previous AMI 37 (11%) 
Previous angina 85 (25%) 
Left ventricular EF < 30% 13 (4%) 
Preoperative serum creatinine in mg/dl* 1.1  0.4 
Preoperative Hb in g/dl* 13  1.7 
Data are expressed as mean  S.D., median (interquartile range) or perce
fraction.
* p < 0.001.
** p = 0.01.endocarditis. Patients with preoperative RD had statistically
signiﬁcant increased use of vasoactive drugs during ECC and
RBC transfusion.
3.3. Postoperative data
The 30-day mortality rate was 2.6% (CI 95%, 1.4–3.8%) and there
was no signiﬁcant difference between both groups. Patients
with preoperative RD had increased duration of mechanical
ventilation, re-intubation, hospital stay, and reoperation for
bleeding (Table 3). No differences were found in major cardiac
events. Postoperative stroke was diagnosed in three patients
(0.7%). Postoperative RRT was needed in four of the 340
patients (0.9%).
Of the 340 patients, 264 patients (77.6%) received RBC
concentrates. Patients with preoperative anemia received
more RBC units (4.5  3.7 vs. 2  2.2, p < 0.0001). Preoperative
anemia was statistically associated with higher postoperative
RD (41% vs. 25%, p < 0.001) but not with mortality (3.8% vs.
2.1%, p = 0.2).
Logistic regression analysis (Table 4) showed that after
adjusting for age and preoperative anemia, preoperative RD
was signiﬁcantly and independently associated with longer
hospital stay and more RBC transfusion.
4. Discussion
In this study, preoperative renal disease was common in
patients undergoing cardiac valve surgery with or without
combined CABG surgery. In addition, it was statistically
associated with prolonged hospital stay and greater number
of units of transfused RBCs.
In our study, patients with preoperative RD were older, had
more co-morbidities, and preoperative anemia. They receivedperative renal dysfunction.
Patients with renal
dysfunction (n = 80)
Patients without renal
dysfunction (n = 260)
72 (66–76) 67 (58–73)
40 (50%) 113 (43%)
160  9 162  9.4
73  13 73  13
28  5.1 28  4.8
57 (71%) 137 (52%)
7 (9%) 38 (15%)
9 (11%) 11 (4%)
21 (24%) 50 (19%)
6 (7.2%) 8 (3%)
8 (10%) 26 (10%)
11 (14%) 29 (11%)
9 (11%) 28 (11%)
19 (24%) 66 (26%)
5 (6%) 8 (3%)
1.5  0.5 0.89  0.2
12.5  1.6 13.1  1.7
ntage (%). COPD, chronic obstructive pulmonary disease; EF, ejection
Table 3 – Postoperative outcomes of patients with and without preoperative renal dysfunction.
Total patients
(n = 340)
Patients with renal
dysfunction (n = 80)
Patients without renal
dysfunction (n = 260)
30-day mortality 9 (2.6%) 3 (3.4%) 6 (2.3%)
Additive Euro SCORE (%)* 6.1  2.8 7.2  2.98 5.7  2.63
Logistic Euro SCORE (%)* 7.8  8.7 10.5  11.4 6.6  6.9
Postoperative ventilation time in hours* 6.2 (4.5–11.1) 7.6 (5–19) 6 (4–6)
MV > 24 h* 17 (5%) 7 (8%) 10 (4%)
ICU stay in days 3 (2–4) 3 (2–4) 2 (2–4)
Hospital stay in days* 8 (7–12) 9 (8–14) 8 (7–11)
Re-intubation** 9 (2.5%) 3 (4.3%) 6 (1.7%)
Reoperation* 12 (3.7%) 6 (6.8%) 6 (2.3%)
Postoperative renal dysfunctiona 102 (30%) 23 (29%) 79 (30%)
Cardiogenic shock 10 (2.8%) 3 (3.4%) 7 (2.5%)
AMI 12 (3.5%) 4 (5.3%) 8 (2.7%)
Ventricular ﬁbrillation 6 (1.6%) 2 (2.4%) 4 (1.3%)
Pneumonia 8 (2.2%) 3 (3.8%) 5 (1.5%)
* p < 0.001.
** p = 0.04.
a Only available in 340 patients.
Table 2 – Surgical characteristics of study patients according to preoperative renal dysfunction.
Total patients
(n = 340)
Patients with renal
dysfunction (n = 80)
Patients without renal
dysfunction (n = 260)
Previous cardiac surgery 37 (11%) 8 (10%) 29 (11%)
Timing of surgery
Elective 323 (95%) 74 (93%) 249 (96%)
Urgent 12 (3.5%) 3 (3.4%) 9 (3.5%)
Emergency* 4 (1.3%) 3 (3.4%) 1 (0.4%)
Operative procedure
Valve 241 (71%) 56 (70%) 185 (72%)
Valve with CABG 95 (28%) 23 (30%) 72 (28%)
Aortic valve 200 (59%) 46 (58%) 154 (59%)
Mitral valve 88 (26%) 21 (27%) 67 (25%)
Aortic and mitral valve 34 (10%) 8 (9%) 26 (10%)
Others 17 (5%) 5 (6%) 12 (5%)
Number of bypass 2 (1–2) 1 (1–2) 2 (1–3)
ECC time in min* 105 (83–126) 111 (86–130) 105 (84–127)
Cross-clamp time in min 83 (65–101) 86 (66–105) 83 (65–101)
ECC vasoactive support** 224 (66%) 60 (74%) 164 (63%)
RBC units* 2.8  2.98 3.8  3.6 2.3  2.6
RBC, red blood cells.
* p < 0.001.
** p < 0.004.
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support during ECC. Euro SCORE overestimated our observed
mortality in both groups, a ﬁnding also demonstrated in recent
studies of patients operated on for cardiac surgery.6 MajorTable 4 – Regression logistic model of risk outcomes in
patients with preoperative renal dysfunction after cardiac
valve surgery.
Variable Odds ratio 95% CI p-value
Age (per one year increase) 1.05 1.03–1.07 <0.001
Preoperative anemia 1.60 1.1–2.40 0.02
Hospital stay 1.02 1.0–1.04 0.05
RBC transfusion 1.09 1.01–1.7 0.02adverse events detected in patients with preoperative RD were
the need for reoperation, longer mechanical ventilation time,
and hospital stay, which is in agreement with previous
reports8; but contrary to these studies, we did not observe
major adverse cardiac events. Our reoperation rate is well
within the accepted 2% and 6% range after cardiac surgery.14
However, logistic regression analysis showed that only
hospital stay and RBC transfusion were independently
associated with preoperative RD.
We did not ﬁnd a relationship between preoperative mild
RD and mortality and neither between preoperative anemia
and mortality after VCS. Anderson et al.8 found that
preoperative serum creatinine level higher than 1.5 mg/dl
was an independent factor of mortality after VCS, but these
authors reported a very high 30-day mortality (16%). Also, we
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anemia such as that found by Cladellas et al.10 in cardiac valve
surgery. We believe that the high mortality reported in both
the studies, the differences in gender, and the timing of
operation preclude a comparison.
Some studies have used the serum creatinine level rather
than the estimated GFR to detect RD, but the National Kidney
Foundation uses GFR rather than the serum creatinine level
to deﬁne RD.12 The MDRD equation was used in our study to
diagnose preoperative RD because it has been shown in
patients undergoing CABG surgery that estimation of GFR is
associated with postoperative renal failure stronger than with
serum creatinine.9 Approximately, one-third of our patients
had an estimated GFR suggestive of mild CKD, a similar
incidence previously reported. Approximately, 26% of our
patients with preoperative serum creatinine lower than
1.2 mg/dl had a GFR < 60 ml/min/1.73 m2, which represents
occult RD, a ﬁnding that supports that serum creatinine levels
can be normal even when renal function is impaired.
Acute renal failure after cardiac surgery is a severe
complication associated with a high mortality rate. The
deﬁnition of ARF has varied widely and many methods have
been used to characterize ARF, and we used a deﬁnition that
was associated with hospital mortality after CABG.13 Interest-
ingly, we ﬁnd the same incidence of postoperative RD in both
groups of patients and the incidence of postoperative RRT was
lower than that reported by previous studies.9
4.1. Limitations
Several limitations have to be considered when interpreting
our results. These data originated from a single Center.
Further, in order to estimate preoperative risk after VCS, our
series seems relatively small to draw ﬁrm conclusions. The
number of events in our study (death, ARF) is small and may
limit the interpretation. The clinical relevance of the incorpo-
ration of an estimated GFR in the preoperative assessment of
VCS seems small and introduces more complexity to the
preoperative assessment process.
5. Conclusion
Patients undergoing VCS with preoperative mild RD are at
increased risk of postoperative morbidity. The association
between preoperative RD and anemia with mortality needs to
be conﬁrmed.
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